From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

ARCHIVED

REACH-B Advice: Form Launch & Case Study Discussion

This course has been archived and is no longer available for enrolment. Visit our Education Library for current courses.

Illustration of a person on virtual call

Upcoming Conferences and Events

Global Prisons Infectious Disease Network (GPIDN) 2nd Annual Conference

30 September 2026 - 2 Oct 2026
Grand Plaza Hotel & Congress Center (Ljubljana, Slovenia)

The 14th International Conference on Health and Hepatitis in Substance Users

6 - 9 Oct 2026
Clarion Congress Hotel Prague (Czech Republic)

APSAD 2026

8 - 11 Nov 2026
Esplanade Hotel Fremantle by Rydges, Walyalup (WA, Australia)